Leerink Partnrs Has Pessimistic View of DSGN Q2 Earnings
Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) – Leerink Partnrs cut their Q2 2025 earnings per share estimates for Design Therapeutics in a report issued on Wednesday, May 7th. Leerink Partnrs analyst J. Schwartz now forecasts that the company will post earnings of ($0.33) per share for the quarter, down from their prior forecast of […]
Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) – Leerink Partnrs cut their Q2 2025 earnings per share estimates for Design Therapeutics in a report issued on Wednesday, May 7th. Leerink Partnrs analyst J. Schwartz now forecasts that the company will post earnings of ($0.33) per share for the quarter, down from their prior forecast of […]
